Effects of hCGRP I and II on gastric blood flow and acid secretion in anesthetized rabbits.
Effects of intravenously administered human calcitonin gene-related peptides (hCGRP) I and II on regional blood flow and gastric acid secretion were examined in barbiturate-anesthetized rabbits. Blood flow was measured by injection of radioactively labeled microspheres at 0, 10, 20, 30, and 60 min. hCGRP I and II and vehicle were infused intravenously in five rabbits in rising doses of 0.01 (0-10th min), 0.03 (11-20th min), and 0.1 microgram.kg-1.min-1 (21-30th min). hCGRP I and II increased gastric blood flow dose dependently. Moreover, hCGRP I raised regional conductance (inverse of vascular resistance) in the stomach, duodenum, heart, brain, and skeletal muscle. As a result of the increased total peripheral conductance the mean arterial pressure was reduced, but the cardiac output remained unchanged. hCGRP II increased blood flow and conductance selectively in the stomach and the pancreas. The total peripheral conductance and mean arterial pressure remained unchanged. Apparently, hCGRP II exerts a more localized effect on the stomach than hCGRP I. hCGRP I and II did not affect basal gastric acid secretion. Pentagastrin-stimulated acid secretion was increased by 28% with hCGRP I (0.025 micrograms.kg-1.min-1) and decreased by 27% with hCGRP II (0.025 micrograms.kg-1.min-1). The inverse effect of hCGRP I and II and the parallel stimulation of blood flow brought about with hCGRP I and II indicate a different mode of action of the peptides on gastric blood flow and gastric acid secretion.
Division de Gastroenterologie, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
P
P
Bauerfeind
R
R
Hof
A
A
Hof
M
M
Cucala
S
S
Siegrist
C
C
von Ritter
J A
JA
Fischer
A L
AL
Blum
D000818:Animals; D002116:Calcitonin; D015740:Calcitonin Gene-Related Peptide; D005744:Gastric Acid / Q000187:drug effects / Q000378:metabolism*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009479:Neuropeptides / Q000494:pharmacology*; D010418:Pentagastrin / Q000494:pharmacology; D011817:Rabbits; D012039:Regional Blood Flow / Q000187:drug effects; D013270:Stomach / Q000098:blood supply* / Q000187:drug effects; D014665:Vasodilator Agents
D009479:Neuropeptides; D014665:Vasodilator Agents; D002116:Calcitonin; D010418:Pentagastrin; D015740:Calcitonin Gene-Related Peptide